Search research articles
Contact Us
Filters
Showing results (1321-1330 of 1,396) with videos related to
Page
of 140
Sort By:
Journal of Clinical Lipidology
|
February 15, 2025
Characterization of lipidic plaque features in association with LDL-C<70 mg/dL and lipoprotein(a) <50 mg/dL
Daisuke Shishikura, Yu Kataoka, Stephen J Nicholls, et al.
Cancer Research
|
October 2, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer
Carolina Gemma, Chun-Fui Lai, Anup K Singh, et al.
Nature Genetics
|
January 15, 2013
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease
Cornelia Kornblum, Thomas J Nicholls, Tobias B Haack, et al.
The New England Journal of Medicine
|
May 8, 2025
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
Stephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
The Lancet. Diabetes & Endocrinology
|
May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
Sophia Zoungas, David D'Alessio, Imre Pavo, et al.
Global Heart
|
November 16, 2022
World Heart Federation Cholesterol Roadmap 2022
Kausik K Ray, Brian A Ference, Tania Séverin, et al.
Nature Chemical Biology
|
October 14, 2008
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase
Elsa D Garcin, Andrew S Arvai, Robin J Rosenfeld, et al.
Science Translational Medicine
|
July 29, 2020
Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation
Maria V Selvadurai, Mitchell J Moon, Simon J Mountford, et al.
Journal of Clinical Lipidology
|
June 24, 2025
Circulating apolipoprotein B levels in statin-treated type 2 diabetic patients with coronary artery disease: Implications for coronary atheroma progression and instability
Sayaka Funabashi, Yu Kataoka, Stephen J Nicholls, et al.
American Heart Journal
|
May 5, 2024
Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN
Stephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
Page
of 140
Search research articles
Search
Showing results (1321-1330 of 1,396) with videos related to
Sort By:
Page
of 140
Journal of Clinical Lipidology
|
February 15, 2025
Characterization of lipidic plaque features in association with LDL-C<70 mg/dL and lipoprotein(a) <50 mg/dL
Daisuke Shishikura, Yu Kataoka, Stephen J Nicholls, et al.
Cancer Research
|
October 2, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer
Carolina Gemma, Chun-Fui Lai, Anup K Singh, et al.
Nature Genetics
|
January 15, 2013
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease
Cornelia Kornblum, Thomas J Nicholls, Tobias B Haack, et al.
The New England Journal of Medicine
|
May 8, 2025
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
Stephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
The Lancet. Diabetes & Endocrinology
|
May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
Sophia Zoungas, David D'Alessio, Imre Pavo, et al.
Global Heart
|
November 16, 2022
World Heart Federation Cholesterol Roadmap 2022
Kausik K Ray, Brian A Ference, Tania Séverin, et al.
Nature Chemical Biology
|
October 14, 2008
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase
Elsa D Garcin, Andrew S Arvai, Robin J Rosenfeld, et al.
Science Translational Medicine
|
July 29, 2020
Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation
Maria V Selvadurai, Mitchell J Moon, Simon J Mountford, et al.
Journal of Clinical Lipidology
|
June 24, 2025
Circulating apolipoprotein B levels in statin-treated type 2 diabetic patients with coronary artery disease: Implications for coronary atheroma progression and instability
Sayaka Funabashi, Yu Kataoka, Stephen J Nicholls, et al.
American Heart Journal
|
May 5, 2024
Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN
Stephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
Page
of 140